Board Meeting14 Aug 2026, 10:10 pm
Parmax Pharma Appoints Additional Directors, Recommends Independent Directors
AI Summary
Parmax Pharma Ltd announced board changes following a meeting on August 14, 2026. Mr. Dhiren Shah and Mr. Sunil Shah were appointed as Additional Directors (Non-Executive). The board also recommended Ms. Anjana Shah and Mr. Ashish Shah as Non-Executive Independent Directors for a term of 5 years, subject to shareholder approval at the upcoming AGM. Additionally, Ms. Salma Thobhani resigned as a non-executive director. The company also approved the Unaudited Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. All newly appointed directors have confirmed they are not debarred from holding office.
Key Highlights
- Two Additional Directors appointed, two recommended as Independent Directors.
- Appointments subject to shareholder approval at the ensuing AGM.
- Unaudited financial results for Q1 FY27 approved.
- One non-executive director resigned from the board.
- All new directors confirmed compliance with SEBI regulations.
Price Impact
More from PARMAX